Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
Launched by IRAN UNIVERSITY OF MEDICAL SCIENCES · Oct 22, 2007
Trial Information
Current as of May 26, 2025
Completed
Keywords
ClinConnect Summary
Eligibility criteria:
Diabetic tractional retinal detachment-complexity score between 4 and 8
Main outcome measures:
best corrected visual acuity-anatomic condition of the retine(re-attachment of the retina)
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Those patients with tractional retinal detachment who are candidated for pars plana vitrectomy.
- • Complexity score between 4 and 8.
- Exclusion Criteria:
- • Previous vitreoretinal surgery.
- • Presence of any other vitreoretinal pathology such as past or present uveitis, and retinal artery or vein occlusion.
About Iran University Of Medical Sciences
The Iran University of Medical Sciences (IUMS) is a leading institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent sponsor of clinical trials, IUMS focuses on a diverse range of medical fields, fostering collaboration among researchers, healthcare professionals, and industry partners. Committed to enhancing patient outcomes and contributing to the global medical community, IUMS adheres to the highest ethical standards and regulatory guidelines in conducting clinical research. Its robust infrastructure and expertise facilitate the development of effective therapies and interventions, ultimately aiming to improve health and well-being in Iran and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tehran, , Iran, Islamic Republic Of
Patients applied
Trial Officials
Mehdi Modarres, MD
Study Director
Iran University of Medical Sciences(IUMS)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials